Promoter hypomethylation of the LINE-1 retrotransposable elements activates sense/antisense transcription and marks the progression of chronic myeloid leukemia
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Induction of tumors in mice by genomic hypomethylation
Gaudet, F., Hodgson, J. G., Eden, A., Jackson-Grusby, L., Dausman, J., Gray, J. W., Leonhardt, H., & Jaenisch, R. (2003) · Science · doi:10.1126/science.1083558 · Cited by 1,499 · cited 1×
“Moreover, genomic hypomethylation causes tumorigenesis in mice associated with the acquisition of additional genomic changes (Eden et al., 2003; Gaudet et al., 2003).”
BackgroundHuman L1 retrotransposon encodes a conserved endonuclease required for retrotransposition
Feng, Q., Moran, J. V., Kazazian, H. H., & Boeke, J. D. (1996) · Cell · doi:10.1016/s0092-8674(00)81997-2 · Cited by 1,139
Hot L1s account for the bulk of retrotransposition in the human population
Brouha, B., Schustak, J., Badge, R. M., Lutz-Prigge, S., Farley, A. H., Moran, J. V., & Kazazian, H. H. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0831042100 · Cited by 1,073 · cited 1×
“It also contains roughly 5000 full-length 6 kb L1 elements, 60–100 of which are still capable of retrotransposition (Brouha et al., 2003).”
BackgroundAsymmetric methylation in the hypermethylated CpG promoter region of the human L1 retrotransposon
Woodcock, D. M., Lawler, C. B., Linsenmeyer, M. E., Doherty, J. P., & Warren, W. D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.12.7810 · Cited by 168 · cited 1×
“Methylation includes symmetric and asymmetric methylation at CpG dinucleotides as well as methylation at non-CpG sites (Woodcock et al., 1997).”
Background
Cited by
Kulis, M., & Esteller, M. (2010) · Advances in Genetics · doi:10.1016/b978-0-12-380866-0.60002-2 · Cited by 1,566
Dna Hypomethylation In Cancer Cells
Ehrlich, M. (2009) · Epigenomics · doi:10.2217/epi.09.33 · Cited by 1,060
DNA hypomethylation and human diseases
Wilson, A. S., Power, B. E., & Molloy, P. L. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.08.007 · Cited by 804
“In most other cancers studied (leukemias, urothelial, ovarian and breast cancers) LINE demethylation increases with the degree of malignancy, and in some cases has been shown to correlate with clinical outcome [71].”
BackgroundInfluentialDecline in genomic DNA methylation through aging in a cohort of elderly subjects
Bollati, V., Schwartz, J., Wright, R., Litonjua, A., Tarantini, L., Suh, H., Sparrow, D., Vokonas, P., & Baccarelli, A. (2009) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2008.12.003 · Cited by 594
Transposable elements in cancer
Burns, K. H. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.35 · Cited by 572
Epigenetic mechanisms in mammals
Kim, J. K., Samaranayake, M., & Pradhan, S. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8432-4 · Cited by 498
A Cohort Study of Tumoral LINE-1 Hypomethylation and Prognosis in Colon Cancer
Ogino, S., Nosho, K., Kirkner, G. J., Kawasaki, T., Chan, A. T., Schernhammer, E. S., Giovannucci, E. L., & Fuchs, C. S. (2008) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djn359 · Cited by 377
Wolff, E. M., Byun, H.-M., Han, H. F., Sharma, S., Nichols, P. W., Siegmund, K. D., Yang, A. S., Jones, P. A., & Liang, G. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1000917 · Cited by 308
Hur, K., Cejas, P., Feliu, J., Moreno-Rubio, J., Burgos, E., Boland, C. R., & Goel, A. (2014) · Gut · doi:10.1136/gutjnl-2012-304219 · Cited by 299
Global DNA Methylation Level in Whole Blood as a Biomarker in Head and Neck Squamous Cell Carcinoma
Ting Hsiung, D., Marsit, C. J., Houseman, E. A., Eddy, K., Furniss, C. S., McClean, M. D., & Kelsey, K. T. (2007) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0636 · Cited by 297
Burns, K. H., & Boeke, J. D. (2012) · Cell · doi:10.1016/j.cell.2012.04.019 · Cited by 293
Daskalos, A., Nikolaidis, G., Xinarianos, G., Savvari, P., Cassidy, A., Zakopoulou, R., Kotsinas, A., Gorgoulis, V., Field, J. K., & Liloglou, T. (2009) · International Journal of Cancer · doi:10.1002/ijc.23849 · Cited by 290
Biomarkers of Lead Exposure and DNA Methylation within Retrotransposons
Wright, R. O., Schwartz, J., Wright, R. J., Bollati, V., Tarantini, L., Park, S. K., Hu, H., Sparrow, D., Vokonas, P., & Baccarelli, A. (2010) · Environmental Health Perspectives · doi:10.1289/ehp.0901429 · Cited by 235
Long interspersed nuclear element-1 hypomethylation in cancer: biology and clinical applications
Kitkumthorn, N., & Mutirangura, A. (2011) · Clinical Epigenetics · doi:10.1007/s13148-011-0032-8 · Cited by 142
Loss of epigenetic silencing in tumors preferentially affects primate-specific retroelements
Szpakowski, S., Sun, X., Lage, J. M., Dyer, A., Rubinstein, J., Kowalski, D., Sasaki, C., Costa, J., & Lizardi, P. M. (2009) · Gene · doi:10.1016/j.gene.2009.08.006 · Cited by 127
Jones, R. B., Garrison, K. E., Wong, J. C., Duan, E. H., Nixon, D. F., & Ostrowski, M. A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001547 · Cited by 99
St. Laurent, G., Hammell, N., & McCaffrey, T. A. (2010) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2010.03.008 · Cited by 68
Metadata
- Authors
- Roman-Gomez, J., Jimenez-Velasco, A., Agirre, X., Cervantes, F., Sanchez, J., Garate, L., Barrios, M., Castillejo, J. A., Navarro, G., Colomer, D., Prosper, F., Heiniger, A., & Torres, A.
- Venue
- Oncogene
- Published
- 2005-09-19
- Volume
- 24
- Issue
- 48
- Pages
- 7213-7223
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2136460560
- Cited by
- 215
- References
- 4
- FWCI
- 5.65
- Type
- journal article
- Language
- en
- Status
- Retracted
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.